Regencell Bioscience Holdings Ltd. (RGC)
22.38
-1.94
(-7.98%)
USD |
NASDAQ |
Jan 21, 13:59
Regencell Bioscience Holdings Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| HUTCHMED (China) Ltd. | 1.800B |
| Sino Biopharmaceutical Ltd. | 17.30B |
| Prenetics Global Ltd. | 251.41M |
| Cellyan Biotechnology Ltd. | -- |
| Charming Medical Ltd. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -0.03% |
| Normalized Earnings Yield | -0.0322 |